Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 2 of 100
Newsletters
Another COVID booster unknown: Will more doses for the vaccinated cause new variants?
By
Sy Mukherjee
Health
What side effects can you expect from the COVID-19 vaccine booster shots?
By
Sy Mukherjee
Health
The most common COVID Delta variant symptoms in adults and kids
By
Sy Mukherjee
Health
Americans ineligible for COVID booster shots are already snagging extra doses
By
Sy Mukherjee
Newsletters
There are no authorized COVID booster shots. More than one million Americans have gotten them anyway
By
Sy Mukherjee
Health
Pfizer’s COVID vaccine may be much less effective against the Delta variant. Should you worry if you got it?
By
Sy Mukherjee
Health
Most parents support masking kids in school. But half of unvaccinated adults won’t get their child a COVID vaccine
By
Sy Mukherjee
Newsletters
Moderna’s unlikely journey to rivaling Big Pharma giants’ valuations
By
Sy Mukherjee
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Sy Mukherjee
Health
Full FDA approval of Pfizer’s COVID vaccine is coming soon. What that means
By
Sy Mukherjee
Health
Nearly half of unvaccinated Americans don’t plan on getting a COVID vaccine
By
Sy Mukherjee
Health
Can you still get ‘long COVID’ if you’re fully vaccinated? Here’s what we know
By
Sy Mukherjee
Newsletters
Offices, employees, and customers: The COVID mask conundrum
By
Sy Mukherjee
Health
What the CDC’s shift on wearing masks indoors means for businesses
By
Sy Mukherjee
Health
What to know about COVID booster shots as the Delta variant spreads
By
Sy Mukherjee